Stockholders’ Equity (Tables)
|
9 Months Ended |
Sep. 30, 2025 |
| Stockholders’ Equity [Abstract] |
|
| Schedule of Restricted Stock Activity |
A
summary of restricted stock activity during the period January 1, 2025 to September 30, 2025 is as follows:
| | |
Total restricted shares | | |
Weighted average fair market value per share | | |
Total unvested restricted shares | | |
Weighted average fair market value per share | | |
Total
vested restricted shares | | |
Weighted average fair market value per share | |
| Outstanding January 1, 2025 | |
| 783,167 | | |
$ | 1.5000 | | |
| - | | |
$ | - | | |
| 783,167 | | |
$ | 1.50 | |
| Granted and issued | |
| 67,500,000 | | |
| 0.0037 | | |
| - | | |
| - | | |
| 67,500,000 | | |
| 0.0037 | |
| Forfeited/Cancelled | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
| Vested | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
| Outstanding September 30 ,2025 | |
| 68,283,167 | | |
$ | 0.0207 | | |
| - | | |
$ | - | | |
| 68,283,167 | | |
$ | 0.0207 | |
|
| Schedule of Restricted Stock Granted, Issued and Exercisable |
The restricted stock granted, issued
and exercisable at September 30, 2025 is as follows:
| | | |
Restricted Stock Granted and Vested | |
| Grant date Price | | |
Number Granted | | |
Weighted Average Fair Value per Share | |
| $ | 0.0037 | | |
| 67,500,000 | | |
| 0.0037 | |
| $ | 1.4700 | | |
| 683,167 | | |
$ | 1.4700 | |
| $ | 1.5000 | | |
| 33,333 | | |
| 1.5000 | |
| $ | 1.6500 | | |
| 66,667 | | |
| 1.6500 | |
| | | | |
| 68,283,167 | | |
$ | 0.0207 | |
|
| Schedule of Fair Value of the Warrants Granted and Issued |
The fair value
of the warrants granted, repriced and issued, as described above, were determined by using a Black Scholes valuation model using the following
assumptions:
| | |
Nine months
ended
September 30,
2025 | |
| Exercise price | |
$ | 0.0005 to 0.084 | |
| Risk free interest rate | |
| 3.77 to 4.46 | % |
| Expected life | |
| 1 month to 5 years | |
| Expected volatility of underlying stock | |
| 183.1 to
352.45 | % |
| Expected dividend rate | |
| 0 | % |
The fair value
of the options granted were determined by using a Black Scholes valuation model using the following assumptions:
| | |
Nine months ended September 30, 2025 | |
| Exercise price | |
$ | 0.09 | |
| Risk free interest rate | |
| 4.67 | % |
| Expected life | |
| Ten years | |
| Expected volatility of underlying stock | |
| 200.7 | % |
| Expected dividend rate | |
| 0 | % |
|
| Schedule of Warrant Activity |
A summary of
warrant activity during the period January 1, 2024 to September 30, 2025 is as follows:
| | |
Shares Underlying Warrants | | |
Exercise price per share | | |
Weighted average exercise price | |
| Outstanding January 1, 2024 | |
| 10,442,093 | | |
$ | 0.345 – 5.625 | | |
$ | 0.626500 | |
| Granted | |
| 1,796,493 | | |
| 0.084 to 0.345 | | |
| 0.267000 | |
| Increase in warrants issued due to anti-dilution price protection | |
| 9,773,028 | | |
| 0.0840 | | |
| 0.084000 | |
| Forfeited | |
| - | | |
| - | | |
| - | |
| Exercised | |
| - | | |
| - | | |
| - | |
| Outstanding December 31, 2024 | |
| 22,011,614 | | |
$ | 0.084 – 5.625 | | |
$ | 0.319900 | |
| Granted | |
| 52,654,761 | | |
| 0.005 to 0.084 | | |
| 0.00474 | |
| Increase in warrants issued due to anti-dilution price protection | |
| 2,157,367,790 | | |
| 0.0005 | | |
| 0.00050 | |
| Forfeited | |
| (531,165 | ) | |
| 0.0005 to 1.035 | | |
| 0.97430 | |
| Exercised | |
| - | | |
| - | | |
| - | |
| Outstanding September 30, 2025 | |
| 2,231,503,000 | | |
$ | 0.0005 – 5.625 | | |
$ | 0.00302 | |
|
| Schedule of Warrants Outstanding and Exercisable |
The warrants outstanding and exercisable
at September 30, 2025 are as follows:
| | | | Warrants Outstanding | | | Warrants Exercisable | | | Exercise Price* | | | Number Outstanding | | | Weighted Average Remaining Contractual life in years | | | Weighted Average Exercise Price | | | Number Exercisable | | | Weighted Average Exercise Price | | | Weighted Average Remaining Contractual life in years | | | $ | 0.000500 | | | | 2,200,712,892 | | | | 2.22 | | | | | | | | 2,200,712,892 | | | | | | | | 2.22 | | | $ | 0.000585 | | | | 20,000,000 | | | | 4.78 | | | | | | | | 20,000,000 | | | | | | | | 4.78 | | | $ | 0.084000 | | | | 2,654,761 | | | | 4.33 | | | | | | | | 2,654,761 | | | | | | | | 4.33 | | | $ | 0.345000 | | | | 7,248,896 | | | | 2.94 | | | | | | | | 7,248,896 | | | | | | | | 2.94 | | | $ | 0.450000 | | | | 266,668 | | | | 2.73 | | | | | | | | 266,668 | | | | | | | | 2.73 | | | $ | 1.500000 | | | | 33,334 | | | | 2.87 | | | | | | | | 33,334 | | | | | | | | 2.87 | | | $ | 4.500000 | | | | 505,560 | | | | 0.46 | | | | | | | | 505,560 | | | | | | | | 0.46 | | | $ | 5.625000 | | | | 80,889 | | | | 0.46 | | | | | | | | 80,889 | | | | | | | | 0.46 | | | | | | | | 2,231,503,000 | | | | 2.25 | | | $ | 0.00302 | | | | 2,231,503,000 | | | $ | 0.00302 | | | | 2.25 | |
|
| Schedule of Option Activity |
A summary of option activity during
the period January 1, 2024 to September 30, 2025 is as follows:
| | |
Shares Underlying options | | |
Exercise price per share | | |
Weighted average exercise price | |
| Outstanding January 1, 2024 | |
| 1,520,002 | | |
$ | 1.20 to 12.00 | | |
$ | 4.46 | |
| Granted | |
| - | | |
| - | | |
| - | |
| Forfeited/Cancelled | |
| (6,667 | ) | |
| 1.20 | | |
| 1.20 | |
| Exercised | |
| - | | |
| - | | |
| - | |
| Outstanding December 31, 2024 | |
| 1,513,335 | | |
$ | 1.20 to 12.00 | | |
$ | 4.47 | |
| Granted | |
| 600,000 | | |
| 0.09 | | |
| 0.09 | |
| Forfeited/Cancelled | |
| (333,334 | ) | |
| 4.50 | | |
| 4.50 | |
| Exercised | |
| - | | |
| - | | |
| - | |
| Outstanding September 30, 2025 | |
| 1,780,001 | | |
$ | 0.09 to 12.00 | | |
$ | 2.989 | |
|
| Schedule of Options Outstanding and Exercisable |
The options outstanding and exercisable
at September 30 2025 are as follows:
| | | | Options Outstanding | | | Options Exercisable | | | Exercise Price* | | | Number Outstanding | | | Weighted Average Remaining Contractual life in years | | | Weighted Average Exercise Price | | | Number Exercisable | | | Weighted Average Exercise Price | | | Weighted Average Remaining Contractual life in years | | | $ | 0.09 | | | | 600,000 | | | | 9.28 | | | | | | | | 375,000 | | | | | | | | 9.28 | | | $ | 1.20 | | | | 13,334 | | | | 6.96 | | | | | | | | 13,334 | | | | | | | | 6.96 | | | $ | 4.50 | | | | 1,166,667 | | | | 6.27 | | | | | | | | 1,166,667 | | | | | | | | 6.27 | | | | | | | | 1,780,001 | | | | 7.29 | | | $ | 2.989 | | | | 1,555,001 | | | $ | 3.408 | | | | 7.29 | |
|